Article

The humoral and cellular immune response of a third dose adenoviral-based vectored vaccine…

medRxiv · 2022 · Supaporn Suparak, author Kobkaew Bumroongthai, author Danai Jantapalaboon, author Phanapat Pairoung, author Sudarat Wongkidakarn, author Chonlada Yodtub, author Wiroj Puangtubtim, author Warangluk Pimpapai, author Sakulrat Soonthorncharttrawat, author Panadda Dhepaksorn, author Surakameth Mahasirimongkol, author

Key facts

Title The humoral and cellular immune response of a third dose adenoviral-based vectored vaccine after a single or 2 shots of inactivated COVID-19 vaccine in healthy adults.
First author Supaporn Suparak, author Kobkaew Bumroongthai, author Danai Jantapalaboon, author Phanapat Pairoung, author Sudarat Wongkidakarn, author Chonlada Yodtub, author Wiroj Puangtubtim, author Warangluk Pimpapai, author Sakulrat Soonthorncharttrawat, author Panadda Dhepaksorn, author Surakameth Mahasirimongkol, author
Journal medRxiv
Published Oct 22, 2022
DOI 10.1101/2022.10.18.512323
Devices mentioned K030408, K073487, K073489, K073490, K822496, K981231
Product codes mentioned CFN, GGL, GKZ, MVU, JIT, KHS

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature